Nanoparticles working in harmony
For decades, researchers have been working to develop nanoparticles that deliver cancer drugs directly to tumors, minimizing the toxic side effects of chemotherapy. However, even with the best of these nanoparticles, only about one percent of the drug typically reaches its intended target. Now, a team of researchers from MIT, the Sanford-Burnham Medical Research Institute, and the University of California at San Diego (UCSD) has designed a new type of delivery system in which a first wave of nanoparticles hones in on the tumor, then calls in a much larger second wave that dispenses the cancer drug. This communication between nanoparticles, enabled by the body's own biochemistry, boosted drug delivery to tumors by more than 40-fold in a mouse study.